STOCK TITAN

NOVACCESS GLOBAL (XSNX) Stock Price, News & Analysis

XSNX OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
7 38 sessions, September 30, 2025 to October 12, 2026
Largest daily move
+400% close of January 22, 2026
1-year change
-66.7% closing prices, September 30, 2025 to October 12, 2026
1-month change
-50% closing prices, September 11, 2026 to October 12, 2026

Company Description

NOVACCESS GLOBAL (OTC: XSNX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.2K.

XSNX has declined 66.7% over the past year. The last closing price was $0.0001.

For FY2024, NOVACCESS GLOBAL reported revenue of $0 and diluted earnings per share of -$0.06.

This page collects what Stock Titan holds for XSNX, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-66.7%
Performance 1 year

NOVACCESS GLOBAL (XSNX) closed at $0.0001 on October 12, 2026. Over the past 12 months, the price has lost 66.7%.

See what a $1,000 investment in XSNX would be worth today

XSNX Metrics & Rankings

Price returns through October 12, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

SEC Filings

NOVACCESS GLOBAL has filed 1 recent SEC filing, including 1 Form 10-K. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all XSNX SEC filings →

Financial Highlights

Diluted earnings per share stood at -$0.06. The company generated -$215K in operating cash flow. The current ratio was 0.01, measuring current assets divided by current liabilities.

$0
Revenue (FY2024)
-$215K
Operating Cash Flow
$0
Gross Profit (FY2024)
—
Net Income (FY2024)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in NOVACCESS GLOBAL (XSNX) currently stands at 439 shares, representing 0.0% of the float.

Days to Cover History

Last 12 Months

Days to cover for NOVACCESS GLOBAL (XSNX) currently stands at 219.5 days, up 21850% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 400%. Across the settlements charted above, it has ranged from 1.0 to 219.5 days.

XSNX Company Profile & Sector Positioning

NOVACCESS GLOBAL (XSNX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing XSNX often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), STATERA BIOPHARMA INC (STAB), RENOVACARE INC (RCAR), COMERA LIFE SCIENCES HLDG (CMRA), and VIRPAX PHARMS INC (VRPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XSNX's relative position within its industry.

Frequently Asked Questions

What is the current stock price of NOVACCESS GLOBAL (XSNX)?

The current stock price of NOVACCESS GLOBAL (XSNX) is $0.0001 as of October 12, 2026.

What is the market cap of NOVACCESS GLOBAL (XSNX)?

The market cap of NOVACCESS GLOBAL (XSNX) is approximately $6.2K. Learn more about what market capitalization means .

What is the revenue of NOVACCESS GLOBAL (XSNX) stock?

The FY2024 revenue of NOVACCESS GLOBAL (XSNX) is $0, from its most recent completed fiscal year.

What is the earnings per share (EPS) of NOVACCESS GLOBAL (XSNX)?

The diluted earnings per share (EPS) of NOVACCESS GLOBAL (XSNX) is -$0.06 for FY2024, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of NOVACCESS GLOBAL (XSNX)?

The operating cash flow of NOVACCESS GLOBAL (XSNX) is -$215K. Learn about cash flow.

What is the current ratio of NOVACCESS GLOBAL (XSNX)?

The current ratio of NOVACCESS GLOBAL (XSNX) is 0.01, measuring current assets divided by current liabilities. Learn about liquidity ratios.

What is the gross profit of NOVACCESS GLOBAL (XSNX)?

The gross profit of NOVACCESS GLOBAL (XSNX) is $0 for FY2024, its most recent completed fiscal year.